Cargando…

Efficacy of Anti-Interleukin-2 Receptor Antibody (Daclizumab) in Reducing the Incidence of Acute Rejection After Renal Transplantation

BACKGROUND: Acute rejection remains a major problem in renal transplantation and represents one of the most important causes of chronic allograft dysfunction and late graft loss. Daclizumab is a genetically engineered human IgG1 monoclonal antibody that binds specifically to the α chain of the inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saghafi, Hossein, Rahbar, Khosrow, Nobakht Haghighi, Ali, Qoreishi, Mohammad, Safdari, Farshad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614279/ https://www.ncbi.nlm.nih.gov/pubmed/23573470 http://dx.doi.org/10.5812/numonthly.1806

Ejemplares similares

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation
por: Sageshima, Junichiro, et al.
Publicado: (2009)

Efficacy of Anti-Interleukin-2 Receptor Antibody in Reducing the Incidence of Acute Rejection After Renal Transplantation
por: Liborio, Alexandre Braga, et al.
Publicado: (2012)

Pharmacodynamic effects of daclizumab in the intrathecal compartment
por: Komori, Mika, et al.
Publicado: (2017)

Renal artery stenosis in kidney transplants: assessment of the risk factors
por: Etemadi, Jalal, et al.
Publicado: (2011)

Spotlight on daclizumab: its potential in the treatment of multiple sclerosis
por: Milo, Ron, et al.
Publicado: (2016)

A randomized controlled trial of daclizumab versus anti-thymocyte globulin induction for heart transplantation
por: Mullen, John C, et al.
Publicado: (2014)

Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis
por: Lin, Yen Chih, et al.
Publicado: (2015)

Recent advances in renal transplantation: antibody-mediated rejection takes center stage
por: Pouliquen, Eric, et al.
Publicado: (2015)

The CD25-binding antibody Daclizumab High-Yield Process has a distinct glycosylation pattern and reduced antibody-dependent cell-mediated cytotoxicity in comparison to Zenapax®
por: Ganguly, Bishu, et al.
Publicado: (2016)

The efficacy of hemiepiphysiodesis for idiopathic knee coronal angular deformity by reconstruction plate and screw: A pilot study
por: Maleki, Arash, et al.
Publicado: (2023)

Therapeutic efficacy of monthly subcutaneous injection of daclizumab in relapsing multiple sclerosis
por: Cohan, Stanley
Publicado: (2016)

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS
por: Scheibe, Franziska, et al.
Publicado: (2018)

Post-Transplant Surveillance and Management of Chronic Active Antibody-Mediated Rejection in Renal Transplant Patients in Europe
por: Rostaing, Lionel P. E., et al.
Publicado: (2023)

Laparoscopic Splenectomy to Salvage Renal Transplants from Severe Acute Antibody-Mediated Rejection
por: Latzko, Michael, et al.
Publicado: (2012)

Single-Cell Transcriptome Analysis of Chronic Antibody-Mediated Rejection After Renal Transplantation
por: Kong, Fanhua, et al.
Publicado: (2022)

Review of daclizumab and its therapeutic potential in the treatment of relapsing–remitting multiple sclerosis
por: Reardon, Jennifer, et al.
Publicado: (2013)

Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program
por: Gold, Ralf, et al.
Publicado: (2016)

GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
por: Luessi, Felix, et al.
Publicado: (2018)

A fatal case of daclizumab-induced liver failure in a patient with MS
por: Stettner, Mark, et al.
Publicado: (2019)

Management of MS Patients Treated With Daclizumab – a Case Series of 267 Patients
por: Rommer, Paulus S., et al.
Publicado: (2020)

Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry
por: Ranganath, Thanmayi, et al.
Publicado: (2020)

Updates on antibody-mediated rejection in intestinal transplantation
por: Wu, Guo-Sheng
Publicado: (2016)

Antibody-mediated rejection after lung transplantation
por: Bery, Amit I., et al.
Publicado: (2020)

Nanomedicines in renal transplant rejection – focus on sirolimus
por: Shen, Li-Jiuan, et al.
Publicado: (2007)

Anti‐interleukin‐6 antibody clazakizumab in late antibody‐mediated kidney transplant rejection: effect on cytochrome P450 drug metabolism
por: Mühlbacher, Jakob, et al.
Publicado: (2021)

Organ Transplantation in Iran before and after Istanbul Declaration, 2008
por: Nobakht Haghighi, A., et al.
Publicado: (2011)

The effect of histopathologic and clinical features on allograft survival in renal transplant patients with antibody-mediated rejection
por: Akagun, Tulin, et al.
Publicado: (2016)

Low proportion of follicular regulatory T cell in renal transplant patients with chronic antibody-mediated rejection
por: Chen, Wen, et al.
Publicado: (2017)

Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection
por: Afzali, Shima, et al.
Publicado: (2021)

Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccination
por: Lin, Yen Chih, et al.
Publicado: (2016)

DRESS Syndrome and Daclizumab Failure—Were Potentially Dangerous Signs Missed in Clinical Trials?
por: Avasarala, Jagannadha
Publicado: (2018)

Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis
por: Karunaratne, Kushan, et al.
Publicado: (2021)

Antibody-Mediated Rejection in Kidney Transplantation: A Review
por: Puttarajappa, Chethan, et al.
Publicado: (2012)

Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012)

Acute antibody-mediated rejection after intestinal transplantation
por: Wu, Guo-Sheng, et al.
Publicado: (2016)

Emerging Therapies for Antibody-Mediated Rejection in Kidney Transplantation
por: Abuazzam, Farah, et al.
Publicado: (2023)

Diagnosis of renal transplant rejection: Banff classification and beyond
por: Jeong, Hyeon Joo
Publicado: (2020)

Acute Antibody-mediated Rejection Coexisting With T Cell–mediated Rejection in Pediatric ABO-incompatible Transplantation
por: Yanagi, Yusuke, et al.
Publicado: (2022)

Rejection of Mouse Renal Cell Carcinoma Elicited by Local Secretion of Interleukin‐2
por: Hara, Isao, et al.
Publicado: (1996)

Endothelin A Receptors Expressed in Glomeruli of Renal Transplant Patients May Be Associated with Antibody-Mediated Rejection
por: Nowańska, Katarzyna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqh8ajjgm157eabctgaf3c1boo